المؤلفون: T. V. Timofeeva, E. G. Googe, N. M. Fatina

المصدر: Эпидемиология и вакцинопрофилактика, Vol 18, Iss 3, Pp 60-64 (2019)

مصطلحات موضوعية: pertussis, morbidity, post-vaccination immunity, vaccine, booster, adacel, safety, Epistemology. Theory of knowledge, BD143-237

وصف الملف: electronic resource

Relation: https://www.epidemvac.ru/jour/article/view/742; https://doaj.org/toc/2073-3046; https://doaj.org/toc/2619-0494

URL الوصول: https://doaj.org/article/9eda3994c97047df8d996bb1ce18bca8

المؤلفون: McClearn, Matthew

المصدر: Canadian Business. 5/26/2003, Vol. 76 Issue 10, p141. 4p. 4 Color Photographs.

مصطلحات موضوعية: *AIR traffic control, *AERONAUTICAL safety measures, *AIRCRAFT accidents, *ACCIDENT prevention, AIR traffic controllers, AIRPORT communication systems

مصطلحات جغرافية: CANADA, UNITED Kingdom, UNITED States

الشركة/الكيان: ADACEL Inc. , GREAT Britain. Royal Air Force

People: PEARSON, Gary

المؤلفون: Sung-Hsi Wei, Yen-Nan Chao, Song-En Huang, Tsuey-Feng Lee, Luan-Yin Chang

المصدر: Pediatrics and Neonatology, Vol 52, Iss 1, Pp 38-41 (2011)

مصطلحات موضوعية: acellular pertussis, adacel, adverse events, children, reduced diphtheria toxoid, Pediatrics, RJ1-570

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1875957210000185; https://doaj.org/toc/1875-9572

URL الوصول: https://doaj.org/article/89cebf9bccd84a3a8ed88c77095b6c09

المؤلفون: Petra Zimmermann, Fiona R. M. van der Klis, Susan Donath, Nigel Curtis, Kirsten P Perrett, Nicole Ritz, Nicole L Messina

المصدر: EClinicalMedicine
EClinicalMedicine, Vol 13, Iss, Pp 21-30 (2019)

مصطلحات موضوعية: Boostrix, MenC, meningococcus type C, Measles-Mumps-Rubella Vaccine, dTpa, diphtheria-tetanus-acellular pertussis vaccine, Non-specific, 01 natural sciences, 0302 clinical medicine, PT, pertussis toxin, Hib, Haemophilus influenzae type b, 030212 general & internal medicine, lcsh:R5-920, Heterologous, Tetanus, Adacel, Vaccination, MMR, measles-mumps-rubella vaccine, Humoral, FHA, filamentous haemagglutinin, General Medicine, BCG, Bacillus Calmette-Guérin vaccine, 3. Good health, Immunisation, Titre, Pertactin, lcsh:Medicine (General), Research Paper, Flu, IgG, immunoglobulin G, MIS BAIR, Melbourne Infant Study: BCG for Allergy and Infection Reduction, complex mixtures, Rubella, Antibodies, 03 medical and health sciences, PRN, pertactin, medicine, Immunoglobulin, FIM, fimbriae, 0101 mathematics, Pregnancy, Heterologous vaccine, business.industry, Diphtheria, 010102 general mathematics, dTpa, medicine.disease, Influenza, CI, confidence interval, HepB, hepatitis B, GMC, geometric mean antibody concentration, Immunology, PCV13, 13-valent conjugate pneumococcal vaccine, TCV, tetanus-containing vaccine, business, GMR, geometric mean antibody ratio, IPV, inactivated polio vaccine, TIV, trivalent inactivated influenza vaccine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3645f4552c6479cf81fd69488252cc5
http://europepmc.org/articles/PMC6733996

مصطلحات موضوعية: Boostrix, IPV, PRN, PT, PCV13, Non-specific, HepB, fimbriae, measles-mumps-rubella vaccine, Bacillus Calmette-Guérin vaccine, GMC, immunoglobulin G, BCG, MenC, diphtheria-tetanus-acellular pertussis vaccine, Heterologous, Adacel, Vaccination, GMR, Humoral, CI, MMR, FHA, Immunisation, Titre, TCV, Flu, tetanus-containing vaccine, IgG, trivalent inactivated influenza vaccine, inactivated polio vaccine, complex mixtures, Antibodies, pertactin, 13-valent conjugate pneumococcal vaccine, Immunoglobulin, Hib, meningococcus type C, pertussis toxin, filamentous haemagglutinin, FIM, Haemophilus influenzae type b, Melbourne Infant Study: BCG for Allergy and Infection Reduction, dTpa, geometric mean antibody concentration, MIS BAIR, Influenza, confidence interval, geometric mean antibody ratio, hepatitis B, TIV

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___00893::9bc3d5beae2a4de4214ef246135c705a

المؤلفون: Zimmermann, Petra, Perrett, Kirsten P, Messina, Nicole L, Donath, Susan, Ritz, Nicole, van der Klis, Fiona R M, Curtis, Nigel

المصدر: EClinicalMedicine

مصطلحات موضوعية: Adacel, Antibodies, BCG, Bacillus Calmette-Guérin vaccine, Boostrix, CI, confidence interval, FHA, filamentous haemagglutinin, FIM, fimbriae, Flu, GMC, geometric mean antibody concentration, GMR, geometric mean antibody ratio, HepB, hepatitis B, Heterologous, Hib, Haemophilus influenzae type b, Humoral, IPV, inactivated polio vaccine, IgG, immunoglobulin G, Immunisation, Immunoglobulin, Influenza, MIS BAIR

Relation: http://hdl.handle.net/10029/623276; EClinical Medicine 2019; 13:21-30

الاتاحة: http://hdl.handle.net/10029/623276
https://doi.org/10.1016/j.eclinm.2019.06.010

المصدر: Economist. 4/17/1993, Vol. 327 Issue 7807, p80-80. 3/8p. 1 Black and White Photograph.

مصطلحات موضوعية: *AUTOMOBILE insurance, *INSURANCE companies, *BUSINESS insurance, *BUSINESS enterprises

مصطلحات جغرافية: GERMANY

الشركة/الكيان: ADACEL Inc.

المؤلفون: Niño Ruiz, Carmen Judith

المساهمون: Morón Duarte, Lina Sofía, Alvarez Larrañaga, Martha Isabel

المصدر: 1. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(40):385-400.
2. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969-87.
3. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. Cmaj. 2005;172(4):509-15.
4. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(1):13-5.
5. Wheeler JG, Simmons AL. Pertussis update. Pediatr Infect Dis J. 2005;24(9):829-30.
6. Tan T. Summary: epidemiology of pertussis. Pediatr Infect Dis J. 2005;24(5 Suppl):S35-8.
7. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr. 2008;167(2):133-9.
8. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005;24(8):721-8.
9. Edwards K, Freeman DM. Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr. 2006;18(1):77-80.
11. Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis. 2004;190(3):535-44.
12. Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med. 2005;353(15):1555-63.
13. Galanis E, King AS, Varughese P, Halperin SA. Changing epidemiology and emerging risk groups for pertussis. Cmaj. 2006;174(4):451-2.
14. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24(5 Suppl):S25-34.
15. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367(9526):1926-36.
16. Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206:902.
17. Bergquist SO, Bernander S, Dahnsjö H, Sundelöf B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458.
18. Bass JW, Klenk EL, Kotheimer JB, et al. Antimicrobial treatment of pertussis. J Pediatr 1969; 75:768.
19. Centers for Disease Control and Prevention (CDC). Pertussis--United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002; 51:73.
20. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32(12):1691-7.
21. Skowronski DM, De Serres G, MacDonald D, Wu W, Shaw C, Macnabb J, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185(10):1448-53.
22. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J. 2003;22(1):22-7.
23. Guiso N, Wirsing von Konig CH, Forsyth K, Tan T, Plotkin SA. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine. 29. Netherlands: Copyright A© 2010. Published by Elsevier Ltd.. All rights reserved.; 2011. p. 1115-21.
24. Nelson JD. The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child 1978; 132:371.
25. Centers for Disease Control and Prevention. Pertussis (Whooping Cough). Pertussis in Other Countries. http://www.cdc.gov/pertussis/countries.html.
26. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 Suppl):S58-61.
27. Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005; 142:832.
28. Hewlett EL, Edwards KM. Clinical practice. Pertussis--not just for kids. N Engl J Med 2005; 352:1215.
29. Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol. 2007;4:15.
30. Cherry JD, Heininger U. Pertussis. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA: W. B. Saunders; 2003.
31. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985.
32. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26:293.
33. Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007; 26:238.
34. Tablas_2013_A_SEM 52. Extraido el 6 de Junio de 2014 desde http://www.ins.gov.co /lineas-de-accion/Subdireccion-Vigilancia /sivigila /Paginas /vigilancia-rutinaria.aspx
35. Informe del evento de la vigilancia de tosferina, hasta periodo epidemiologico cuatro (IV) del año 2014. Version: 01. Extraido el 6 de junio de 2014 desde http://www.ins.gov.co:81/lineas-de-accion/Subdireccion-Vigilancia/Informe %20de%20Evento%20Epidemiolgico/TOSFERINA%20Periodo%20IV%202014. pdf
36. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics. 1997;100(6):E10.
37. Nieves DJ, Singh J, Ashouri N, et al. Clinical and laboratory features of pertussis in infants at the onset of a California epidemic. J Pediatr 2011; 159:1044.
38. Bortolussi R, Miller B, Ledwith M, Halperin S. Clinical course of pertussis in immunized children. Pediatr Infect Dis J 1995; 14:870.
39. Tozzi AE, Ravà L, Ciofi degli Atti ML, et al. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003; 112:1069.
40. Couzigou C, Flahault A. Is pertussis being considered as a cause of persistent cough among adults? Eur J Epidemiol 2003; 18:1013.
41. Harnden A, Grant C, Harrison T, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006; 333:174.
42. Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/ Bordetella parapertussis. Geneva, World Health Organization, 2007 (WHO/ IPV/04.14). Also available from http://www.who.int/immunization/documents/ WHO_IVB_04.14/en/index.html.)
43. Riffelmann M, Wirsing von Konig CH, Caro V, Guiso N. Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43(10):4925-9.
44. Njamkepo E et al. Thirty-five years’ experience with the whole-cell pertussis vaccine in France:vaccine strains analysis and immunogenicity. Vaccine, 2002, 20:1290–1294.
45. Lai FY, Thoon KC, Ang LW, Tey SH, Heng D, Cutter JL, et al. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine. 2012;30(24):3566-71.
46. Okada K, Komiya T, Yamamoto A, Takahashi M, Kamachi K, Nakano T, et al. Safe and effective booster immunization using DtaP in teenagers. Vaccine. 2010;28(48):7626-33.
47. Camenga DR, Kyanko K, Stepczynski J, Flaherty-Hewitt M, Curry L, Sewell D, et al. Increasing adult Tdap vaccination rates by vaccinating infant caregivers in the pediatric office. Acad Pediatr. 2012;12(1):20-5.
48. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005;24(6 Suppl):S104-8.
49. de Carvalho AP, Pereira EM. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J). 2006;82(3 Suppl):S15-24.
50. Singh M, Lingappan K. Whooping cough: the current scene. Chest. 2006;130(5):1547-53.
51. Griffiths AH. Permanenent brain damage and pertussis vaccination: is the end of the saga in sight? Vaccine 1989;7:199–210.
52. Protocolo de vigilancia en salud publica Tosferina, Version 03. Extraido el 6 de Junio de 2014 desde http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia /sivigila / Protocolos%20SIVIGILA/PRO%20Tos%20ferina.pdf
53. Cohen S, Black A, Ross A, Mandel ED. Updated treatment and prevention guidelines for pertussis. Jaapa. 2014;27(1):19-25, quiz 6.
54. Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(6):817-40.
55. Cherry JD. Pertussis vaccines for adolescents and adults. Pediatrics. 2005;116(3):755-6.
56. Halperin SA. Pertussis–a disease and vaccine for all ages. N Engl J Med. 353. United States2005. P. 1615-7.
57. Akinsanya-Beysolow I, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group, Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2014. MMWR Morb Mortal Wkly Rep 2014; 63:108.
58. de Greeff SC, Mooi FR, Westerhof A, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010; 50:1339.
59. Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations. Vaccine. 2012;30(35):5179-90.
60. Food and Drug Administration. Product approval information-licensing action, package insert: BOOSTRIX®. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. GlaxoSmithKline Biologicals. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005.
61. Food and Drug Administration. Product approval information-licensing action, package insert: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed ADACELTM. Sanofi celula. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2006.
62. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006;117(3):965-78.
63. Wilson TR. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis. J Pediatr Health Care. 2006;20(4):229-37.
64. Lineamiento Estratégico para la Introducción de la Vacuna TdaP (Tétanos-Difteria-Tos ferina acelular) en el Esquema del Programa Ampliado de Inmunizaciones –PAI Para Mujeres Gestantes de las cohortes 2013 y 2014. Extraido el 6 de Junio de 2014 desde http://www.minsalud.gov.co /Documentos %20y%20Publicaciones/Lineamiento%20Estrat%C3%A9gico%20para%20la%20Introducci%C3%B3n%20de%20la%20Vacuna%20TdaP.pdf
65. Protocolo Tos Ferina 2013. Extraido el 6 de Junio de 2014 desde http://www.ins.gov.co/Noticias/Memorias%20Reunin%20Nacional%20de%20Vigilancia%20y%20Control%20e/2-8-tosferina.pdf
66. Pichichero ME, Casey JR, Francis AB, Marsocci SM, Murphy M, Hoeger W, et al. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules. Clin Pediatr (Phila). 2006;45(7):613-20.
67. Tran Minh NN, He Q, Ramalho A, Kaufhold A, Viljanen MK, Arvilommi H, et al. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Pediatrics. 1999;104(6):e70.
68. Pichichero ME, Rennels MB, Edwards KM, Blatter MM, Marshall GS, Bologa M, et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. Jama. 2005;293(24):3003-11.
69. Southern J, Andrews N, Burrage M, Miller E. Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine. 2005;23(29):3829-35.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

مصطلحات موضوعية: adacel, pertussis vaccine, teenagers, Resultado del Tratamiento, Vacunación [Tétanos], Tétanos y Tos Ferina Acelular, boostrix, Enfermedades, teens, Vacunación [Tos ferina], Vacunación [Difteria], adolescent, Efectividad, Vacunas contra Difteria, treatment outcome, Adolescente, Vacuna contra Difteria, Tétanos y Tos Ferina

وصف الملف: application/pdf; Documento

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2c43807b4c3d0f5f54b36838178dd9
http://repository.urosario.edu.co/handle/10336/6363

المؤلفون: Kirby, James

المصدر: BRW. 9/26/2002, Vol. 24 Issue 38, p79. 1/2p.

مصطلحات موضوعية: *CORPORATE finance, *COMPUTER software industry

مصطلحات جغرافية: AUSTRALIA

الشركة/الكيان: ADACEL Technologies Ltd. 020866377

المؤلفون: Kirby, James

المصدر: BRW. 12/13/2001, Vol. 23 Issue 49, p79. 1/2p. 1 Color Photograph.

مصطلحات موضوعية: *SOFTWARE engineering, *COMPUTER software developers

مصطلحات جغرافية: VICTORIA, MELBOURNE (Vic.)

الشركة/الكيان: ADACEL Technologies Ltd. 020866377

المصدر: Air Traffic Management. Summer2010, Issue 2, p13-13. 1/8p.

مصطلحات موضوعية: AIR traffic control simulators

مصطلحات جغرافية: UKRAINE

الشركة/الكيان: ADACEL Inc.

المصدر: Air Traffic Management. Fall2009, Issue 3, p33-33. 1/3p.

مصطلحات موضوعية: *AIR traffic control, *GREENHOUSE gas mitigation, *AUTOMATIC machinery, *MANAGEMENT, AIR pollution prevention

مصطلحات جغرافية: NORTH Atlantic Region

الشركة/الكيان: ADACEL Systems Inc.

المصدر: Air Traffic Management. Winter2008, Vol. 17 Issue 4, p13-13. 1/3p.

مصطلحات موضوعية: *AIR traffic control, *CONTRACTS, *AUTOMATION, *MANAGEMENT

الشركة/الكيان: ADACEL Inc. , NAV Portugal (Company)

المصدر: Air Traffic Management. Autumn2008, Vol. 17 Issue 3, p19-19. 1p.

مصطلحات موضوعية: *BUSINESS development, *STRATEGIC alliances (Business), AIDS to air navigation

الشركة/الكيان: ADACEL Inc. , NAV Portugal (Company)

المصدر: Air Traffic Management. Summer2008, Vol. 17 Issue 2, p37-37. 1/8p.

مصطلحات موضوعية: *COMPUTER software

الشركة/الكيان: ADACEL Technologies Ltd. 020866377

المصدر: Air Traffic Management. Spring2008, Vol. 17 Issue 1, p20-20. 1/3p.

مصطلحات موضوعية: AIR traffic control equipment, AIR traffic control electronic equipment, COMPUTER simulation

مصطلحات جغرافية: UNITED States

الشركة/الكيان: ADACEL Inc. , UNITED States. Federal Aviation Administration

المصدر: Air Traffic Management. Winter2006, Vol. 15 Issue 4, p17-17. 1/9p.

مصطلحات موضوعية: *AIR traffic control

الشركة/الكيان: ADACEL Inc.

المصدر: Air Traffic Management. Winter2006, Vol. 15 Issue 4, p4-4. 1/6p.

مصطلحات موضوعية: *EXECUTIVES, AERONAUTICS

مصطلحات جغرافية: UNITED States

الشركة/الكيان: ADACEL Inc.

People: STEVENS, Marcus

المصدر: Air Traffic Management. Fall2006, Vol. 15 Issue 3, p39-39. 1p. 2 Color Photographs.

مصطلحات موضوعية: *COMPUTER software industry, *AUTOMATION, AIR traffic control software, AIR traffic control simulators

الشركة/الكيان: ADACEL Inc.

المؤلفون: Knapton, Tim

المصدر: BRW. 7/20/2006, Vol. 28 Issue 28, p69-69. 1/2p. 1 Color Photograph.

مصطلحات موضوعية: *CORPORATE growth, *CORPORATE finance, *EMERGING markets, AIR traffic control electronic equipment

مصطلحات جغرافية: BRIGHTON (Vic.), VICTORIA

الشركة/الكيان: ADACEL Technologies Ltd. 020866377